SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

AIM ImmunoTech Inc.
Date: June 27, 2025 · CIK: 0000946644 · Accession: 0001641172-25-016920

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-286319

Date
June 27, 2025
Author
Feiner
Form
CORRESP
Company
AIM ImmunoTech Inc.

Letter

VIA EDGAR Division of Corporation Finance Securities and Exchange Commission F Street, NE Washington, DC 20549 Re: AIM ImmunoTech Inc. (the "Company") Registration Statement on Form S-3, SEC file no.: 333-286319

Dear Sir or Madam:

On behalf of the Company we file herewith Amendment No. 1 to the above referenced registration statement on Form S-3, a universal shelf registration.

Previously, the Company received a no-review letter. Assuming that the Commission still will not be reviewing the registration statement, the Company plans on seeking effectiveness as soon as possible.

Please direct any questions or comments to the undersigned, Richard Feiner, Esq., 646 822-1170 ( rfeiner@silverfirm.com ).

The contact person at the Company is Peter W. Rodin III, COO. His e-mail address is Peter.rodino@aimimmuno.com and his phone number is (239) 444-1743.

Very
truly yours,
/s/ Richard
Feiner

Show Raw Text
CORRESP
 1
 filename1.htm

 SILVERMAN
SHIN & BYRNE PLLC

 Wall
Street Plaza

 22nd
Floor

 88
Pine Street

 NEW
YORK, NY 10005

 212.779.8600

 Facsimile:
212.779.8858

 New
Jersey

 19
Engle Street

 Tenafly,
NJ 07670

 (201)
567-4969

 June
27, 2025

 VIA
EDGAR

 Division
of Corporation Finance

 Securities
and Exchange Commission

 100
F Street, NE

 Washington,
DC 20549

 Re:
 AIM ImmunoTech Inc. (the
 "Company")

 Registration Statement on Form S-3, SEC file no.: 333-286319

 Dear
Sir or Madam:

 On
behalf of the Company we file herewith Amendment No. 1 to the above referenced registration statement on Form S-3, a universal shelf
registration.

 Previously,
the Company received a no-review letter. Assuming that the Commission still will not be reviewing the registration statement, the Company
plans on seeking effectiveness as soon as possible.

 Please
direct any questions or comments to the undersigned, Richard Feiner, Esq., 646 822-1170 ( rfeiner@silverfirm.com ).

 The
contact person at the Company is Peter W. Rodin III, COO. His e-mail address is Peter.rodino@aimimmuno.com and his phone number
is (239) 444-1743.

 Very
truly yours,

 /s/ Richard
Feiner

 Richard
Feiner

 cc:
AIM ImmunoTech Inc.